Patients ask doctors
Can you sequence my genome?
Enter brave new world
One word description
Newly approved cancer drugs
Unaffordable
Hot biotech trend
Virtual drug companies
Who will do research?
Can’t be denied now
Obamacare launch shaky
Improvements needed
Biosimilars
Challenges remain ahead
Gold mine, or fools gold?
Hype is well deserved
Immunotherapy soars
Keeping fingers crossed
Big pharma layoffs
World of hurt for smart people
Fries with that burger?
Payments to docs stopped
GSK sets example
Will others follow?
Orphan diseases
Big Pharma disdained, now loves
New hope for the few
IPO window
Best jump through it while you can
May close tomorrow
Drug regulations
Disliked by industry but
Safety paramount
Best research advice
Embrace collaborations
Experts can help you
Antibiotics
Still desperately needed
Bacteria change
Inevitable
Mergers and acquisitions
Good for some, not all
Healthcare in U.S.
Broken system needs repair
Wish I lived in France
Hot technology
CRISPR – Can fix broken genes
Godsend if it works
Next blockbuster drugs
Cholesterol lowering
Outcomes not required?
Pharma mindset changed
Who is our customer now?
Patient or payer?
Schekman wins Nobel
Goodbye Cell, Science, Nature
Easy for him to say
Can’t afford your meds?
Insurance copays too high?
Hello Canada
Feel free to add your own haiku in the comments section below!
